Prevalence and duration of detectable SARS-CoV-2 nucleocapsid antibodies in staff and residents of long-term care facilities over the first year of the pandemic (VIVALDI study): prospective cohort study in England.

Research paper from Europe PMC. Evidence status: source reported.

Published

2021-12-16

Source reference

MED:34935001

DOI

10.1016/s2666-7568(21)00282-8

Jurisdiction

Not assessed

Licence

Bibliographic metadata only; article rights retained

Krutikov M, Palmer T, Tut G, Fuller C, Azmi B, Giddings R, Shrotri M, Kaur N, Sylla P, Lancaster T, Irwin-Singer A, Hayward A, Moss P, Copas A, Shallcross L. · Lancet Healthy Longev · research support, non-u.s. gov't; research-article; journal article · Found via: ClinicalTrials.gov result publication

Source: https://europepmc.org/article/MED/34935001. Captured 2026-10-29.

Limitations: Listed by a ClinicalTrials.gov registration as a result publication of that study, and fetched by its PubMed ID. The registry's listing is the sponsor's statement; it does not confirm which data the paper used. Preprints may not be peer reviewed.